Trial Watch · Emergency & Critical Care

Clinical trials in Emergency & Critical Care, ranked by methodological rigor and ordered by most recent.

70 trials indexed
Favipiravir Safe, Well-Tolerated for Mild-to-Moderate Lassa Fever
PIVOTAL TRIAL · LAST 30 DAYS
Randomized Controlled Trial Nature Medicine

Favipiravir Safe, Well-Tolerated for Mild-to-Moderate Lassa Fever

A phase 2 trial in Nigeria provides pharmacokinetic data and supports favipiravir as an alternative to ribavirin for Lassa fever.

May 17, 2026 Read the trial →
Astegolimab Reduces COPD Exacerbations in Broad Patient Population Randomized Controlled Trial
American Journal of Respiratory and Critical Care Medicine

Astegolimab Reduces COPD Exacerbations in Broad Patient Population

A pooled analysis of two trials shows astegolimab significantly lowers moderate/severe exacerbation rates in patients with frequent COPD…

May 19, 2026
Armchair Positioning Improves Oxygenation in Spontaneously Breathing ICU Patients Randomized Controlled Trial
Intensive care medicine

Armchair Positioning Improves Oxygenation in Spontaneously Breathing ICU Patients

A randomized controlled trial found out-of-bed armchair positioning increased PaO2/FiO2 ratios compared to in-bed semi-recumbent positioning.

May 18, 2026
Digital Decision Aid Boosts STI Testing in ED for Young Adults Randomized Controlled Trial
Annals of emergency medicine

Digital Decision Aid Boosts STI Testing in ED for Young Adults

A randomized trial shows a smartphone-based tool significantly increases gonorrhea/chlamydia and pharyngeal STI testing rates in emergency department

May 17, 2026
Anti-C5a Antibody STSA-1002 Shows Favorable Safety, Reduced Mortality in ARDS Randomized Controlled Trial
CHEST Journal

Anti-C5a Antibody STSA-1002 Shows Favorable Safety, Reduced Mortality in ARDS

A phase 1b/2 trial indicates STSA-1002 is well tolerated and associated with lower 28-day mortality in viral pneumonia-induced ARDS.

May 17, 2026
ED Nudge Strategy Increases Naltrexone Prescribing for Alcohol Misuse Non-Randomized Controlled Trial
Annals of emergency medicine

ED Nudge Strategy Increases Naltrexone Prescribing for Alcohol Misuse

A multicomponent emergency department protocol significantly raised naltrexone initiation for patients with alcohol-related diagnoses.

May 17, 2026
Thrombectomy Improves Functional Independence in Medium-Vessel Occlusion Stroke Randomized Controlled Trial
New England Journal of Medicine

Thrombectomy Improves Functional Independence in Medium-Vessel Occlusion Stroke

A randomized trial shows endovascular thrombectomy increases functional independence but also raises symptomatic intracranial hemorrhage risk in mediu

May 16, 2026
Intravenous Magnesium Sulfate Reduces Rescue Analgesia for Acute Headache Randomized Controlled Trial
Annals of emergency medicine

Intravenous Magnesium Sulfate Reduces Rescue Analgesia for Acute Headache

A randomized trial finds adjunctive magnesium sulfate increases treatment success and patient satisfaction, despite pain reduction not meeting clinica

May 16, 2026
Daratumumab-VCd Improves Survival, Organ Function in AL Amyloidosis Randomized Controlled Trial
Blood

Daratumumab-VCd Improves Survival, Organ Function in AL Amyloidosis

Final ANDROMEDA analysis confirms sustained benefits of D-VCd for newly diagnosed light-chain amyloidosis, including overall survival.

May 16, 2026
Ensitrelvir Reduces COVID-19 Incidence by 6.1% in Household Contacts Randomized Controlled Trial
New England Journal of Medicine

Ensitrelvir Reduces COVID-19 Incidence by 6.1% in Household Contacts

An oral SARS-CoV-2 3C-like protease inhibitor significantly lowers infection rates when given as postexposure prophylaxis.

May 16, 2026
Sutureless Robotic Partial Nephrectomy Noninferior to Renorrhaphy for Renal Tumors Randomized Controlled Trial
European urology

Sutureless Robotic Partial Nephrectomy Noninferior to Renorrhaphy for Renal Tumors

A randomized controlled trial indicates sutureless off-clamp robotic partial nephrectomy offers comparable surgical quality for cT1-2N0M0 renal tumors

May 15, 2026
Telitacicept Reduces Proteinuria in IgA Nephropathy: Phase 3 Interim Analysis Randomized Controlled Trial
New England Journal of Medicine

Telitacicept Reduces Proteinuria in IgA Nephropathy: Phase 3 Interim Analysis

A dual BAFF and APRIL antagonist significantly lowers urinary protein-to-creatinine ratio in adults with IgA nephropathy at high risk of progression.

May 15, 2026
Patient-Level Adherence Drives Enhanced Recovery Benefits in Pediatric GI Surgery Randomized Controlled Trial
JAMA Surgery

Patient-Level Adherence Drives Enhanced Recovery Benefits in Pediatric GI Surgery

A stepped-wedge trial shows that while site-level ERP implementation may not reduce length of stay, patient-level adherence does.

May 14, 2026
Lower Oxygen Saturation Target Reduces Pediatric Hospital Stay, Oxygen Therapy Randomized Controlled Trial
PubMed

Lower Oxygen Saturation Target Reduces Pediatric Hospital Stay, Oxygen Therapy

A multicenter trial suggests targeting 88% peripheral oxygen saturation in children with acute respiratory illness shortens hospitalizations.

May 14, 2026
Intra-Arterial Alteplase Improves Recovery After Successful Thrombectomy Randomized Controlled Trial
JAMA

Intra-Arterial Alteplase Improves Recovery After Successful Thrombectomy

Adjunctive thrombolysis increased 90-day functional independence by 15% but was associated with a nearly 6% increase in mortality.

May 13, 2026
Tirzepatide Reduces Major Kidney Events More Than Dulaglutide Randomized Controlled Trial
lancet. Diabetes & endocrinology

Tirzepatide Reduces Major Kidney Events More Than Dulaglutide

In patients with type 2 diabetes and cardiovascular disease, tirzepatide lowered the risk of renal outcomes by 23% over four years.

May 13, 2026
Dihydroartemisinin-Piperaquine Reduces Early Plasmodium vivax Recurrence Compared With Chloroquine Randomized Controlled Trial
Lancet. Infectious diseases

Dihydroartemisinin-Piperaquine Reduces Early Plasmodium vivax Recurrence Compared With Chloroquine

A randomized trial in Brazil shows dihydroartemisinin-piperaquine effectively prevents early malaria recurrence when primaquine is delayed.

May 13, 2026
Tenecteplase Before Thrombectomy Does Not Improve Late-Window Stroke Outcomes Randomized Controlled Trial
JAMA

Tenecteplase Before Thrombectomy Does Not Improve Late-Window Stroke Outcomes

A phase 3 trial in patients with proximal MCA occlusions found no functional benefit to adding tenecteplase between 4.5 and 24 hours.

May 13, 2026
Single Sigmoidoscopy Reduces Male Colorectal Cancer Death at 23 Years Randomized Controlled Trial
Annals of Internal Medicine

Single Sigmoidoscopy Reduces Male Colorectal Cancer Death at 23 Years

A Norwegian trial shows a single screening sigmoidoscopy provides long-term protection for men, but mortality benefits are absent in women.

May 13, 2026
Digoxin Reduces Heart Failure Risk in Rheumatic Heart Disease Randomized Controlled Trial
JAMA

Digoxin Reduces Heart Failure Risk in Rheumatic Heart Disease

A randomized trial in India shows low-dose digoxin decreases the composite risk of death or worsening heart failure by 18 percent.

May 12, 2026
Low-Dose Digoxin Fails to Reduce Heart Failure Events in Randomized Trial Randomized Controlled Trial
Nature Medicine

Low-Dose Digoxin Fails to Reduce Heart Failure Events in Randomized Trial

A study of 1,001 patients found targeting low serum concentrations did not significantly lower mortality or urgent hospital visits.

May 12, 2026
Small Vessel Disease Explains Reduced Thrombectomy Benefit in Older Patients Randomized Controlled Trial
Annals of Neurology

Small Vessel Disease Explains Reduced Thrombectomy Benefit in Older Patients

A secondary analysis of the RESILIENT trial finds that CT markers of brain frailty, not age alone, predict poor functional outcomes.

May 12, 2026
CDR132L Fails to Improve Ventricular Volume After Myocardial Infarction Randomized Controlled Trial
Nature Medicine

CDR132L Fails to Improve Ventricular Volume After Myocardial Infarction

A phase 2 trial of the microRNA-132 inhibitor CDR132L showed no significant benefit in structural or functional endpoints at six months.

May 12, 2026
NXT007 Reaches Nonhemophilic Factor VIII Levels in Severe Hemophilia A Non-Randomized Controlled Trial
Blood

NXT007 Reaches Nonhemophilic Factor VIII Levels in Severe Hemophilia A

A phase 1/2 trial shows monthly subcutaneous NXT007 achieves factor activity above 40 IU/dL and eliminates bleeds at higher doses.

May 11, 2026
Tirofiban Improves 90-Day Outcomes After Inadequate Tenecteplase Response Randomized Controlled Trial
JAMA

Tirofiban Improves 90-Day Outcomes After Inadequate Tenecteplase Response

Adjunctive tirofiban increased the rate of functional independence in patients with non-large vessel stroke who failed to improve.

May 11, 2026
Prophylactic Antiemetics Fail to Reduce Opioid-Induced Nausea in Prehospital Trauma Non-Randomized Controlled Trial
Scandinavian Journal of Trauma Resuscitation and Emergency Medicine

Prophylactic Antiemetics Fail to Reduce Opioid-Induced Nausea in Prehospital Trauma

A prospective study of 205 HEMS patients shows no benefit for routine intravenous ondansetron or isopropanol aromatherapy.

May 10, 2026
Ivermectin Fails to Improve Outcomes in Hospitalized COVID-19 Patients Randomized Controlled Trial
Critical Care Medicine

Ivermectin Fails to Improve Outcomes in Hospitalized COVID-19 Patients

A randomized trial shows no benefit for organ support-free days or survival in critically and noncritically ill patients.

May 10, 2026
Individualized Algorithm Lowers Achilles Rerupture Risk and Limits Unnecessary Surgery Randomized Controlled Trial
British Journal of Sports Medicine

Individualized Algorithm Lowers Achilles Rerupture Risk and Limits Unnecessary Surgery

The CARTA protocol uses ultrasound criteria to select patients for surgery, reducing reruptures by 73% compared to non-operative management.

May 09, 2026
Higher Ivermectin Dose Does Not Improve Severe Scabies Cure Rates Randomized Controlled Trial
New England journal of medicine

Higher Ivermectin Dose Does Not Improve Severe Scabies Cure Rates

A randomized trial shows 400 μg/kg of ivermectin plus permethrin is not superior to the standard 200 μg/kg dose for crusted scabies.

May 08, 2026
Ketamine Shows No Sustained Hemodynamic Advantage Over Propofol During Intubation Randomized Controlled Trial
Intensive Care Medicine

Ketamine Shows No Sustained Hemodynamic Advantage Over Propofol During Intubation

A randomized trial in critically ill patients found that ketamine-induced blood pressure benefits were transient and did not improve survival.

May 08, 2026